By contributing an additional Rs 42 crore to GoApptiv, the Indian pharmaceutical major Cipla has advanced its efforts in the field of digital health.
With this investment, Cipla will have made three total in GoApptiv, using a mix of stock and compulsorily convertible preferred shares. Through the deal, the former will own a total of 22.99% of the digital tech company, as reported by Inc42.
Read also - ONGC launches Shared Finance Services in collaboration with IBM to revolutionize Vendor Payment Processes
“With this move, we aim to utilise GoApptiv’s technology to strengthen our presence across the healthcare continuum, especially to the underserved population by enabling greater access to lifesaving treatments,” Cipla said in a statement.
There are 27 states, more than 200,000 villages, 3,424 markets, 3,100 Tehsils, and 618 districts that GoApptiv has been able to reach because of their mix of unique technology and on-ground field force.
Read also - Space Startups Jumped from 1 in 2014 to 189 in 2023: Union Minister Jitendra Singh
“Our long-standing partnership with GoApptiv has helped us increase penetration in underserved rural areas of India and address critical healthcare gaps where pharmaceutical coverage is limited,” said Umang Vohra, managing director and global chief executive officer at Cipla Limited.
By utilising economies of scale, their end-to-end solutions give pharmaceutical firms the digital infrastructure they need to grow their reach quickly and affordably.
Read also - Angel One Appoints Hemen Bhatia as CEO of Asset Management Business
About GoApptiv
With its innovative "phygital" concept that gives rural and extra-urban India access to high-quality healthcare, GoApptiv is transforming the pharmaceutical and healthcare industries in India. Their platform seeks to empower all stakeholders in the healthcare ecosystem, enhance patient experiences, foster organisational growth, and promote dynamic market access.
Read also - actyv.ai Appoints Benny Abraham as Managing Director – India and South Asia